Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jay Giri

Interventional Cardiology Philadelphia, PA Medical Doctor

NPI 1881892669 CMS profile 221962

3400 Civic Center Blvd, East Pavilion, 2Nd Floor, Philadelphia, PA 19104

Open in the dashboard

General payments

$156,895

363 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$875,590 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Jay Giri of Philadelphia, PA is reported in the CMS Open Payments database as having received $156,895 across 363 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $875,590 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $32,937 81
2024 General $48,203 96
2023 General $38,028 67
2022 General $16,811 35
2021 General $3,001 26
2020 General $11,436 22
2019 General $6,478 36

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jay Giri
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Jay Giri were reported at $32,937. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Jay Giri Interventional Cardiology median Middle half National median
2019 $6,478 $1,097 $329–$3,048 $163
2020 $11,436 $473 $161–$1,480 $114
2021 $3,001 $677 $233–$1,827 $132
2022 $16,811 $978 $333–$2,724 $149
2023 $38,028 $1,136 $382–$2,986 $160
2024 $48,203 $1,181 $395–$3,326 $164
2025 $32,937 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $60,177 77 payments
  2. Inari Medical, Inc. $40,759 34 payments
  3. Edwards Lifesciences Corporation $16,677 55 payments
  4. AstraZeneca Pharmaceuticals LP $8,224 15 payments
  5. Abiomed $6,239 21 payments
  6. Endovascular Engineering Inc. $5,446 7 payments
  7. Novartis Pharmaceuticals Corporation $4,015 3 payments
  8. Abbott Laboratories $3,866 12 payments
  9. Medtronic Vascular, Inc. $3,139 17 payments
  10. Cordis US Corp. $2,960 3 payments
  11. Other $5,392 119 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $86,038 46 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $28,300 8 payments
  3. Food and Beverage $15,614 264 payments
  4. Travel and Lodging $14,443 40 payments
  5. Honoraria $9,500 3 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $2,500 1 payment
  7. Grant $500 1 payment
Products named General payments · program years 2019–2025
  1. CT THROMBECTOMY SYSTEM KIT $33,997 30 payments
  2. FLOWTRIEVER CATHETER, S $33,997 30 payments
  3. General - Therapies $14,800 6 payments
  4. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $9,115 12 payments
  5. BRILINTA $8,055 12 payments
  6. ClotTriever $6,830 5 payments
  7. FlowTriever $6,830 5 payments
  8. Impella $6,216 20 payments
  9. EkoSonic $5,595 4 payments
  10. Helo Thrombectomy System $5,446 7 payments
  11. Other $19,981 210 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$72,265

Medicare's payments for the services billed

Medicare patients

193

Average age 75

Services billed

513

68 women, 125 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 61%
Chronic kidney disease 48%
Atrial fibrillation 47%
Arthritis 46%
Diabetes 45%
COPD 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

363 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record